NTRK1 and alveolar soft part sarcoma: For unresectable tumors, however, ASPS is resistant to conventional chemotherapies, indicating the need for novel therapeutic targets such as receptor tyrosine kinase inhibitors and other anti-angiogenic agents in the treatment of ASPS (Mitton and Federman, 2012).